FDA Inspection
Teligent Pharma, Inc.Teligent Pharma, Inc. – FDA Inspection, Oct 19, 2017
Record Details
This FDA Inspection record concerns Teligent Pharma, Inc., with an inspection on October 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 849e2f32-f078-471b-9a6e-44718b9300d3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1032023
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Teligent Pharma, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 31, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2019 | Not classified | New Jersey District Office | Drug Quality Assurance |
| January 22, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teligent Pharma, Inc.
- FDA Inspection 1150271 - 2021-08-31
- FDA Inspection 1090090 - 2019-05-20
- FDA Inspection 956413 - 2016-01-22
- FDA Inspection 859472 - 2013-12-19
- FDA Inspection 765396 - 2012-02-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.